MARKET

GELS

GELS

Gelteq Limited
NASDAQ
0.8640
+0.0090
+1.05%
After Hours: 0.8200 -0.044 -5.09% 19:55 01/08 EST
OPEN
0.8500
PREV CLOSE
0.8550
HIGH
0.8650
LOW
0.8260
VOLUME
18.14K
TURNOVER
--
52 WEEK HIGH
4.110
52 WEEK LOW
0.7701
MARKET CAP
9.25M
P/E (TTM)
-1.8673
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GELS last week (1229-0102)?
Weekly Report · 3d ago
Weekly Report: what happened at GELS last week (1222-1226)?
Weekly Report · 12/29/2025 10:11
Weekly Report: what happened at GELS last week (1215-1219)?
Weekly Report · 12/22/2025 10:11
Gelteq Secures $1.3 Million Sales Agreement With Shenzhen Mana Health Management
Reuters · 12/16/2025 14:05
Weekly Report: what happened at GELS last week (1208-1212)?
Weekly Report · 12/15/2025 10:18
Gelteq Limited Unveils Innovative Drug Delivery Platform in Investor Summit
TipRanks · 12/09/2025 20:47
Gelteq entered into three year sales agreement with Mana Health
TipRanks · 12/09/2025 14:20
Gelteq Signs 3-Year China Distribution Deal With Mana To Expand Nutritional Product Portfolio; Expects To Derive A Minimum Revenue Of ~$1.3M During The Term Of The Agreement
Benzinga · 12/09/2025 14:16
More
About GELS
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Webull offers Gelteq Ltd stock information, including NASDAQ: GELS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GELS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GELS stock methods without spending real money on the virtual paper trading platform.